PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2051332
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2051332
Amniotic Membrane Market is estimated to be valued at USD 5.23 Bn in 2026 and is expected to reach USD 12.46 Bn by 2033, growing at a compound annual growth rate (CAGR) of 13.2% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 5.23 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 13.20% | 2033 Value Projection: | USD 12.46 Bn |
Amniotic membrane is an avascular layer of fetal membrane which can be extracted from placenta and stored in a sterile environment right after collection. It can be efficiently used in surgical procedures and in the treatment of ocular diseases or disorders such as ligneous conjunctivitis, corneal disease, etc. as well as for treating tissue damage. An amniotic membrane transplant (AMT) can be done using traditional suture and fibrin glue approach or by an advanced suture-less approach as well. AMT can be used to protect damaged tissues, stimulate growth of new cells, and reduce inflammation and pain by decreasing friction in the eyelids. According to a study published by the National Center for Biotechnology Information (NCBI) in February 2022, 94.3% of people who had undergone amniotic membrane transplant reported of healed epithelial defects while 88% people reported symptomatic relief from symptoms such as dryness, discomfort and pain.
Market players are focused on research and development activities to obtain approvals for novel products or techniques associated with amniotic membrane, this could contribute to the growth of the market over the forecast period. For instance, in 2018, MiMedx, an American biomedical company received the status of Regenerative Medicine Advanced Therapy (RMAT) by the U.S. Food and Administration for its product AmnioFix, an amniotic membrane that is designed for use in osteoarthritis treatment.
Market players are focusing on product launches, which is expected to strengthen their position in the global market. For instance, on February, 2021, Integra LifeSciences, an American medical technology company launched AmnioExcel Plus amniotic membrane that helps in wound care.
Market players are involved in expanding their global presence by adopting strategies such as acquisitions and partnerships, this is expected to drive the growth of the amniotic membrane market globally. For instance, in 2017, Organogenesis Holdings Inc., an American regenerative medicine company acquired NuTech Medical, an American biologics company, to expand their company product portfolio and support the development of next generation amniotic membrane products.